EMA recommends daraxonrasib for metastatic pancreatic cancer after a fast-tracked phased review
On 15 October 2026 the EMA recommended authorising Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma.
On 15 October 2026 the EMA recommended authorising Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma.
A systematic review in the Aesthetic Surgery Journal pooled 65 randomised trials with 18,581 participants.
The UK health department proposed new limits on high-risk cosmetic procedures in England on 21 October 2026.
A systematic review in Plastic and Reconstructive Surgery pooled 12 studies with 29,357 patients.
On 20 October 2026 WHO published State of inequality: noncommunicable diseases and their risk factors.
On 21 October 2026 WHO and three UN agencies launched the first priority indicators on heat and maternal and child health.
On 19 October 2026 WHO published the Global Breast Cancer Initiative (GBCI) Training Manual.
Comedian Katherine Ryan said she will have the breast implants she received in 2004 removed.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one vial of NAD+ injection because their sterility cannot be assured.
A Dermatologic Surgery study reviewed laws and regulations on Botox and filler injections in all 50 US states and DC.
Nothing more to show